DARK FOREST CAPITAL MANAGEMENT LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
DARK FOREST CAPITAL MANAGEMENT LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$232,998
+23199.8%
24,195
+20579.5%
0.02%
Q3 2022$1,000
-99.9%
117
-99.9%
0.00%
-100.0%
Q1 2022$1,293,000
+8520.0%
102,785
+9085.4%
0.30%
+5960.0%
Q3 2021$15,000
+66.7%
1,119
+52.7%
0.01%
+25.0%
Q2 2021$9,0007330.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders